ZFGN


Biotech Beat: MannKind Corporation (MNKD), Inovio Pharmaceuticals Inc (INO), Zafgen Inc (ZFGN)

MannKind Corporation On Thursday January 21, 2016 MannKind Corporation (NASDAQ:MNKD) had announced that it had entered into a license agreement, with a newly …

Biotech Beat: Analysts Weigh In On Relypsa Inc (RLYP), Sarepta Therapeutics Inc (SRPT), Zafgen Inc (ZFGN) And Clovis Oncology Inc (CLVS)

Yesterday was a great day for biotech stocks. The iShares Nasdaq Biotechnology ETF (NASDAQ:IBB), which tracks 144 biotech and pharmaceutical companies, reversed losses and surged …

Company Update (NASDAQ:ZFGN): Zafgen Inc’s Pivotal Phase 3 Trial of Beloranib in Prader-Willi Syndrome Achieves Co-Primary Efficacy Endpoints

Zafgen Inc (NASDAQ:ZFGN), a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by obesity and complex metabolic disorders, …

Biotech Beat: Analysts Weigh In On Zafgen Inc (ZFGN) and Intercept Pharmaceuticals Inc (ICPT)

Never a dull moment in the volatile biotechnology sector as analysts remain bullish on Intercept Pharmaceuticals Inc (NASDAQ:ICPT) as the company prepares to …

Stock Update (NASDAQ:ZFGN): Zafgen Inc Announces Beloranib IND Placed on Complete Clinical Hold

Zafgen Inc (NASDAQ:ZFGN), a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by obesity and complex metabolic disorders, received …

Analysts Weigh In On Two Collapsing Biotechs: Zafgen Inc (ZFGN), OncoGenex Pharmaceuticals Inc (OGXI)

Analysts are weighing in on the biopharmaceutical companies Zafgen Inc (NASDAQ:ZFGN) and OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI), as shares of both companies fell sharply today due …

Company Update (NASDAQ:ZFGN): Zafgen Inc Provides Clinical Update on Beloranib

Zafgen Inc (NASDAQ:ZFGN), a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by obesity and complex metabolic disorders, today …

Company Update (NASDAQ:ZFGN): Zafgen Inc Announces Third Quarter 2015 Financial Results

Zafgen Inc (NASDAQ:ZFGN), a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by obesity and complex metabolic disorders, today …

Company Update (NASDAQ:ZFGN): Zafgen Inc Announces Beloranib Program Update

Zafgen Inc (NASDAQ:ZFGN), a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by obesity and complex metabolic disorders, today …

Biotech Beat: RXi Pharmaceuticals Corp (RXII), Zafgen Inc (ZFGN), Five Prime Therapeutics Inc (FPRX)

RXi Pharmaceuticals Corp On October 15, 2015, RXi Pharmaceuticals Corp (NASDAQ:RXII) announced positive phase 2a results for its RXI-109 compound. The trial, known …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts